Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

10.56
Delayed Data
As of Feb 24
 +0.20 / +1.93%
Today’s Change
2.44
Today|||52-Week Range
13.40
+20.14%
Year-to-Date
How High Can Array BioPharma Inc. Stock Go?
Feb 21 / MotleyFool.com - Paid Partner Content
Want to Get In on Biotech? Check Out These 3 Stocks
Feb 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close10.36
Today’s open10.37
Day’s range10.31 - 10.77
Volume1,983,018
Average volume (3 months)4,128,140
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-9.63%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp+0.30+0.54%
PTLAPortola Pharmaceutic...+1.34+4.17%
SRPTSarepta Therapeutics...+1.87+6.20%
PCRXPacira Pharmaceutica...-0.45-1.03%
Data as of 4:03pm ET, 02/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts


Search for Jobs